中樑控股(02772.HK):陳紅亮及李和慄將為公司聯席執行總裁
格隆匯6月5日丨中樑控股(02772.HK)公佈,由於其他個人事務,黃春雷先生已退任執行董事並辭任公司的首席執行官職務,自股東周年大會結束後生效。黃先生已確認,彼與董事會並無意見分歧,亦無有關彼退任及辭任的其他事宜須敦請公司股東垂注。
黃先生辭任公司首席執行官後,集團執行董事兼聯席總裁陳紅亮先生及李和慄先生將為公司的聯席執行總裁,負責集團業務的管理工作,自股東周年大會結束後生效。陳紅亮先生將專注於集團的業務策略、人力資源、機制會計、法律、風險及財務管理、房地產信息管理及品牌建設;而李和慄先生將專注於集團的投資、產品開發、銷售及客户服務以及業務運營監督。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.